Development by UCLA-led research team works to keep blood sugar at normal levels
UCLA bioengineers and their colleagues have developed a new type of insulin that could help prevent hypoglycemia in people who use the drug to manage diabetes.
The treatment is being evaluated for potential clinical trials and, if successful, could change diabetes care. The study was published in the Proceedings of the National Academy of Sciences.
Insulin is a hormone naturally produced in the pancreas. It helps the body regulate glucose, which is consumed through food and provides the body with energy.
Diabetes occurs when a person’s body does not naturally produce insulin (Type 1 diabetes), or does not efficiently use the insulin that is produced (Type 2). In either case, a regular dosage of insulin is prescribed to manage the disease, which affects more than 400 million people worldwide.
Generally, people who need to use insulin monitor their blood sugar levels with a glucose meter or continuous glucose monitoring system and then calculate their insulin dose accordingly. In addition, a regular carbohydrate intake is important to keep the blood sugar levels normal. Both of these requirements are necessarily subject to human error, which can have potentially devastating consequences.
An overdose of insulin can cause hypoglycemia, when blood sugar is too low. That could lead to seizures, coma, and in extreme cases, death.
As a safety check, the UCLA-led team has developed a type of “smart” insulin, called i-insulin, that can prevent blood sugar levels from dipping too low.
Inside the body, insulin acts as a “key” to help glucose get into cells from the bloodstream. When insulin attaches to a cell’s surface, it activates a protein inside the cell, called glucose transporter, which then makes its way to the cell’s surface. This molecule then brings the surrounding glucose from the blood into the cell.
The research team added an additional molecule to insulin to create the new smart insulin. This added molecule, called a glucose transporter inhibitor, chemically blocks the glucose transporter molecule that has come to the surface. Its presence doesn’t block all glucose from entering, nor does it permanently block the transporter molecules. Instead, it’s part of a dynamic process that depends on how many inhibitor and glucose molecules are present.
“Our new i-insulin works like a ‘smart’ key,” said the study’s principal investigator Zhen Gu, a professor of bioengineering at the UCLA Samueli School of Engineering. “The insulin lets glucose get into the cell, but the added inhibitor molecule prevents too much from going in when blood sugar is normal. This keeps blood sugar at normal levels and reduces the risk of hypoglycemia.”
“This i-insulin can also rapidly respond to high glucose levels,” added Jinqiang Wang, the study’s co-lead author and a postdoctoral researcher in Gu’s research group. “For example, after a meal, when glucose levels climb, the insulin level in the bloodstream also quickly increases, which helps normalize the glucose level.”
The UCLA-led research team tested the smart insulin on mice with Type 1 diabetes. The i-insulin controlled glucose levels within the normal range for up to 10 hours after a first injection. A second injection three hours later extended the protection from hypoglycemia.
“The next step is to further evaluate the long-term biocompatibility of the modified insulin system in an animal model before determining whether to move to clinical trials,” said co-author Dr. John Buse, a professor and director of the Diabetes Care Center at the University of North Carolina School of Medicine. “The vision, if realized, would be one of the most exciting advances in diabetes care.”
“The new insulin has the potential to be optimized for response times and how long it could last in the body before another dose would be required,” Gu said. “And it could be delivered in other methods, such as a skin patch with tiny needles, or in pills.”
The Latest on: Diabetes
via Google News
The Latest on: Diabetes
- Type 2 diabetes symptoms: Polyuria is a sign the body has become resistant to insulinon January 21, 2021 at 12:56 am
TYPE 2 diabetes is a health condition whereby the body has built a resistance to the hormone insulin. Multiple factors lead to this, including excess body weight. How do you know if you're affected?
- Strict Low-Carb Diets Could Push Type 2 Diabetes Into Remission, But Effect Fadeson January 21, 2021 at 12:27 am
Tough limits on carbohydrates in your meals can help get type 2 diabetes under control -- but the benefits typically wane over time, a new research review shows.
- Diabetes type 2 symptoms: Diabetic ulcers are a visual warning sign of high blood sugaron January 20, 2021 at 12:30 pm
DIABETES type 2 often slips under the radar until high blood sugar levels start to inflict damage. One telltale sign blood sugar levels are out of control is the emergence of diabetic ulcers.
- Insulin resistance, diabetes and metabolic syndrome contribute to premature coronary events in womenon January 20, 2021 at 11:23 am
While deaths related to heart disease have declined among older people, studies suggest that death rates among younger patients have remained stagnant or increased slightly.
- Tips for Parents of Kids With Diabeteson January 20, 2021 at 10:05 am
Kids with diabetes can lead full, fun lives, but they have special needs. Here's what parents should know. Diabetes is common among American children. More than 205,000 kids and teens have the disease ...
- Diabetes powerfully associated with premature coronary heart disease in womenon January 20, 2021 at 8:04 am
While deaths related to heart disease have declined among older people, studies suggest that death rates among younger patients have remained stagnant or increased slightly. To understand what factors ...
- Forecasting Diabetes Policy Priorities for 2021on January 20, 2021 at 5:33 am
With a new presidential administration taking over the helm in the United States, the road ahead for American healthcare and policies impacting diabetes stands at a crossroads. The ongoing COVID-19 ...
- Digital Diabetes Management Market To Display Significant Growth $26.4 Billion By 2026 With an Impressive CAGR Of 19.4% | Grand View Research, Incon January 19, 2021 at 8:40 pm
Market Research And Consulting.”” According to a report published by Grand View Research, the market is propelled by ...
- Over-Reliance on Diabetes Technology Might Be a Thingon January 19, 2021 at 8:08 pm
Some people with diabetes are becoming obsessed with the newest tech tools, and find themselves lost without them.
- Is There a Link Between Type 2 Diabetes and Air Pollution?on January 19, 2021 at 4:00 pm
Emerging scientific studies suggest being exposed to air pollution may influence risk for diabetes and make the disease harder to manage if you already have it. Here’s a look at the research.
via Bing News